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A Ab bs st tr ra ac ct t
Gene expression profiling is a powerful method by which alterations in gene expression can be interrogated in 
a single experiment. The disease familial adenomatous polyposis (FAP) is associated with germline mutations
in the APC gene, which result in aberrant β-catenin control. The molecular mechanisms underlying colorectal
cancer development in FAP are being characterised but limited information is available about other symptoms
that occur in this disorder. Although extremely rare in the general population, desmoid tumours in approximately
10% of FAP patients. The aim of this study was to determine the similarities and differences in gene expression
profiles in adenomas and compare them to those observed in desmoid tumours. Illumina whole genome gene
expression BeadChips were used to measure gene expression in FAP adenomas and desmoid tumours. Similarities
between gene expression profiles and mechanisms important in regulating formation of FAP adenomas and
desmoid tumours were identified. This study furthers our understanding of the mechanisms underlying FAP and
desmoid tumour formation.
I In nt tr ro od du uc ct ti io on n
Familial adenomatous polyposis (FAP) is a rare form
of colorectal cancer caused by germline mutations in
the adenomatous polyposis coli (APC) gene.
Approximately 70-90% of FAP patients have identifiable
germline mutations in APC [1, 2]. FAP is clinically
characterized by the formation of hundreds to thousands
of adenomas that carpet the entire colon and rectum
[3]. Although initially benign the risk of malignant
transformation increases with age such that, if left
untreated, colorectal carcinoma usually develops before
the age of 40 years [4].
Loss of APC results in dysregulation of the Wnt
signalling pathway that leads to the constitutional activation
of the transcription factor Tcf-4, which has been associated
with adenoma formation [5]. Alterations in Wnt signalling
cause stem cells to retain their ability to divide in the upper
intestinal crypt, thereby forming monocryptal adenomas
[6]. Eventually the adenomas may acquire metastatic
potential, resulting in carcinoma development [7]. Not all
adenomas will progress to malignant tumours; however,
due to the abundance of adenomas carcinoma
development is virtually assured [8]. 
Apart from the apparent loss of APC function, little
is known about the molecular processes involved inH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 80
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adenoma initiation [6]. Similarly, the molecular events
occurring during the transformation of adenomas into
carcinomas are poorly understood, as are the
mechanisms that underlie the development of extra-
colonic disease in FAP . 
It is well established that FAP patients are susceptible
to benign extra-colonic tumours, including desmoid
tumours [3]. Although rare in the general population,
desmoids occur in approximately 10% of FAP patients
and they are the second most common cause of death
[9]. Desmoid tumours are poorly encapsulated and
consist of spindle-shaped fibroblast cells with varying
quantities of collagen [10]. Despite their apparent
inability to metastasize, desmoid tumours can be
extremely aggressive [11].
It has been speculated that desmoid formation is 
a result of an abnormal wound healing response [12].
Desmoids can affect surrounding viscera, causing
potentially fatal complications [13]. FAP-associated
desmoid tumours are usually associated with germline
APC mutations [14], but somatic APC mutations have
been detected in sporadic desmoid tumours [15]. 
Microarray technology has an enormous potential for
applications in the endeavour to better understand
tumours and their development [16]. The ability to detect
expression levels of thousands of genes can identify
particular genes that are either up- or down-regulated in
different tumour types [17]. Tumours that are currently
categorized by similar morphology, such as desmoid
tumours, may be more usefully divided into subtypes
according to their expression profiles [18]. Particular
expression profiles in tumours may also be capable of
predicting the clinical outcome in specific patients in the
early stages of tumour development [18]. In colorectal
cancer, gene expression profiles of adenomas and
adenocarcinomas have been compared and subsets of
genes expressed at common levels in both lesions have
been identified as well as expression patterns that are
unique to each [19]. Gene expression profiling has the
potential to identify factors involved in the malignant
transformation of adenomas, and may aid in the
diagnosis of benign versus malignant disease.
Although genome-wide expression studies have been
reported on FAP adenomas and desmoid tumours, the
present one of the first to compare the two tissue types.
The first aim of this study was to identify distinct gene
expression profiles for colorectal and stomach FAP
adenomas and desmoid tumours. The second aim was
to determine the similarity between the gene expression
profiles in FAP adenomas and desmoid tumours to identify
mechanisms important in regulating formation of these
lesions. To achieve this, mRNA from normal colon, FAP
stomach and colon adenomas and desmoid tumours
was measured using whole human genome expression
BeadChips (Illumina). The findings of this study further
our understanding of the mechanisms underlying FAP
and desmoid tumour formation.
M Ma at te er ri ia al ls s   a an nd d   m me et th ho od ds s
F FA AP P  a ad de en no om ma a  a an nd d  t tu um mo ou ur r  t ti is ss su ue e  a an nd d  c co on nt tr ro ol ls s
Frozen adenoma tissue from 4 FAP patients was
available for this study. Colorectal FAP adenoma A was
from an individual aged 40 at the time of surgery.
Genetic testing revealed a heterozygous A5465T
change in the APC gene, causing a missense change
from aspartic acid to valine at position 1822 in the
amino acid sequence. The specimen obtained for this
study was obtained as a result of a proctocolectomy.
The pathology report indicated that over 100
tubulovillous adenomas were present in the original
specimen, with no evidence of invasive tumour. Patients
B, C and D harboured the same frameshift mutation,
a 4 base pair deletion at position 3462-3465 of the
APC gene. Patient B was diagnosed with FAP at the age
of 11 years, patient C at 13 years of age, and patient
D at the age of 37 years. One gastric adenoma was
obtained from patient D, in addition to a colonic
adenoma. Normal colon tissue from 7 healthy
individuals with no history of FAP or desmoid disease
was used as a mixed reference sample for this study. 
D De es sm mo oi id d  D Di is se ea as se e  T Ti is ss su ue e  
Desmoid tumour tissue from two individuals was
available for this study. Patient A had FAP-associated
desmoid disease. There was a family history of FAP , but
no known history of desmoid disease. The individual
harboured a 1bp deletion in exon 15 of the APC gene
resulting in a frameshift that introduced a premature stop
codon at amino acid position 964. Patient B had a family
history of FAP and desmoid disease. This patient
harboured a 17bp duplication in exon 15 of the APC
gene, which introduced a premature stop codon at amino
acid position 1969. A previously established fibroblast
cell line from a healthy individual with no history of FAP
or desmoid disease was used as a control for this study.
The fibroblast cell line was cultured in 1x Complete
DMEM media at 37°C (5% CO2).
R RN NA A  E Ex xt tr ra ac ct ti io on n
2-3 mm
2 pieces of fresh frozen FAP adenoma and
desmoid tumour tissue were cut from the original sample
and transferred immediately to 1ml Trizol reagent
(Invitrogen, USA). Similarly, approximately 1-10 x 10
6
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(Invitrogen, USA). RNA was extracted per manufacturer’s
instructions. The RNA pellet was washed with 75%
ethanol, before being dissolved in 20 µl water. 
The total RNA was purified using a Qiagen RNeasy
MiniElute Cleanup Kit as per manufacturer’s
instructions. The concentration of the purified total RNA
samples was measured using a Quant-It RiboGreen
RNA Assay Kit (Invitrogen, USA) and a fluorometer
(Fluostar OPTIMA) as per manufacturer’s instructions. 
R RN NA A  a am mp pl li if fi ic ca at ti io on n
To synthesise first and second strand cDNA and
amplify biotinylated cRNA from the total RNA, an
Illumina Totalprep RNA Amplification Kit was used as
per manufacturer’s instructions. 
The purified cRNA samples were quantified to
determine the volume required for the BeadChip
hybridisation step via the Quant-iT RiboGreen RNA
Assay Kit as described previously.
I Il ll lu um mi in na a  B Be ea ad dC Ch hi ip p  P Pr ro oc ce ed du ur re e
Hybridisation to the Illumina Sentrix 8 BeadChip
was performed according to the manufacturer’s
instructions without modification. The Sentrix 8
BeadChips were read using an Illumina Beadarray
reader (San Diego, CA, USA).
D Da at ta a  A An na al ly ys si is s
Analysis and normalisation of expression data from
the 24,000 transcripts was carried out using
BeadStudio 2.0 (Illumina, San Diego, CA, USA). The
t-test error model and cubic spline normalisation was
used for all samples. A differential analysis was applied
to all adenoma and tumour samples using the Illumina
custom test of significance, utilising the mixed normal
colon control as the reference group. GeneSpring 5.0
(Agilant, Santa Clara, CA, USA) used standard
correlation and distance to create dendrograms
(Experiment trees) to show relationships between gene
expression profiles. A second dendrogram (Gene tree)
was created for each gene list using standard
correlation and distance to show relationships between
the expression levels of genes across the groups.
R Re es su ul lt ts s
Gene expression data from over 23,000 genes on
Illumina HumRef-8 BeadChips was analysed and
normalised using Illumina BeadStudio 2.0 software.
Cubic spline normalisation and the t-test error model
were employed for all the FAP adenoma, normal colon
and desmoid tumour samples. Correlation analyses
identified the average R
2 value of the duplicates for
each sample as 0.950±0.04. An average of each
duplicate pair was then taken before additional analysis
was carried out.
D Di if ff fe er re en nt ti ia al l  g ge en ne e  e ex xp pr re es ss si io on n  a an na al ly ys si is s  i in n  F FA AP P  a ad de en no om ma as s  
a an nd d  h he ea al lt th hy y  c co ol lo on n  t ti is ss su ue e
Differential analysis using the mixed normal colon
control as the reference group was applied to all
adenoma and tumour samples. Genes in each analysis
were excluded if their fluorescence detection score was
less than 0.99, and if their differential score was less
than 13 (p>0.05). From the genes that met the
exclusion criteria, according to detection and
differential scores, lists were generated for genes both
up- and down-regulated more than 2-fold in the FAP
adenoma samples compared to the mixed normal
colon control. The genes commonly up- and down-
regulated across all the FAP adenomas are shown in
Tables 1 and 2 and genes that were commonly up- or
down-regulated across the 4 colorectal FAP adenomas
only are shown in Tables 3 and 4 respectively. 
Cluster analysis was performed using GeneSpring
5.0 software in order to further characterise the
similarity across the FAP samples and to determine if
there was differential gene expression compared to
healthy colon tissue. The stomach FAP duplicates
display profiles slightly distinct from the other FAP
adenomas. The normal colon duplicate profiles are
unique to all other profiles (Figure 1).
D Di if ff fe er re en nt ti ia al l  g ge en ne e  e ex xp pr re es ss si io on n  a an na al ly ys si is s  i in n  d de es sm mo oi id d  t tu um mo ou ur rs s  
a an nd d  c co on nt tr ro ol l  f fi ib br ro ob bl la as st ts s  
The average expression in the desmoid tumours was
compared to the control fibroblast cell line and
significantly altered expression identified by differential
gene expression analysis. Genes in each analysis were
excluded if their fluorescence detection score was less
T Ta ab bl le e   1 1. .   Genes commonly up-regulated more than 2-fold in all FAP
polyps compared to normal colon
S Sy ym mb bo ol l G Ge en ne e   N Na am me e
Transcription/Transcriptional Regulation
TBPL1 TBP-like 1
Other
ZCWCC2 Zinc finger, CW-type with coiled-coil domain 2
KIAA1324 Maba1
FLJ20366 Hypothetical protein FLJ20366
ATOH8 Atonal homolog 8 (Drosophila)H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 82
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T Ta ab bl le e   2 2. .   Genes commonly down-regulated more than 2-fold in all FAP polyps compared to normal colon
S Sy ym mb bo ol l G Ge en ne e   N Na am me e
Cell Cycle Control
PPP3CB Protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta)
Transport
SLC20A1 Solute carrier family 20 (phosphate transporter), member 1
P2RX4 Purinergic receptor P2X, ligand-gated ion channel, 4, tv-2
Metabolism
PC Pyruvate carboxylase, nuclear gene encoding mitochondrial protein, tv-2
PRSS3 Protease, serine, 3 (mesotrypsin)
ST6GALNAC6 CMP-NeuAC: (beta)-N-acetylgalactosaminide (alpha) 2,6-sialyltransferase member IV
Signal Transduction
IL2RG Interleukin 2 receptor, gamma (severe combined immunodeficiency)
TJP3 Tight junction protein 3 (zona occludens 3)
Cell Adhesion
CDC42 Cell division cycle 42 (GTP binding protein, 25kDa), tv-2
GSN Gelsolin (amyloidosis, Finnish type), tv-2
TAGLN Transgelin
Apoptosis
DAPK3 Death-associated protein kinase 3
Structural
KRT19 Keratin 19
TPM2 Tropomyosin 2 (beta)
Other
CTGF Connective tissue growth factor
EPS8L2 EPS8-like 2
LRRC1 Leucine rich repeat containing 1
NS5ATP13TP2 NS5ATP13TP2 protein 
PTPRR Protein tyrosine phosphatase, receptor type, R, tv-2
RICH1 RhoGAP interacting with CIP4 homologs 1
SMTN Smoothelin, tv-2
than 0.99, and if their differential score was less than 13
(p>0.05). Genes with differential expression and up- or
down-regulated more than 2-fold in the desmoid tumour
samples compared to the normal fibroblast cell line were
compiled into lists (Tables 5 and 6).
To reveal any correlation between the expression
profiles of desmoid tumours and FAP adenomas, the data
from each group were compared. In the upper
dendrogram (Figure 2) it can be seen that all the FAP
adenomas cluster in the same group. The desmoid
tumours and the normal fibroblast cell line clustered in
an entirely different group to the FAP samples. The FAP
adenomas and the normal colon have distinct gene
profiles compared to the desmoid tumours and the
normal fibroblasts. Within the FAP adenomas, the
stomach adenoma and the normal colon have slightly
different gene profiles compared to the colorectal
adenomas.
D Di is sc cu us ss si io on n
In this study, 24K Illumina HumRef-8 BeadArrays were
used to compare gene expression of FAP adenomas,
desmoid tumours and normal fibroblasts. To date there
have been a number of small scale gene expression
studies on FAP adenoma tissue, the vast majority of which
have employed immunohistochemistry (IHC). Most of
these studies have been performed on individual genesH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 83
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T Ta ab bl le e   3 3. .   Genes commonly up-regulated 2-fold or more in colorectal FAP polyps compared to normal colon
S Sy ym mb bo ol l G Ge en ne e   N Na am me e
Cell Cycle Control
CCNB2 Cyclin B2
CDKN3 Cyclin-dependent kinase inhibitor 3
AURKB Aurora kinase B
Cell Cycle
HCAP-G Chromosome condensation protein G
PRC1 Protein regulator of cytokinesis 1, tv-1
KIF2C Kinesin family member 2C
CHC1 Chromosome condensation 1
SMC4L1 SMC4 structural maintenance of chromosome 4-like 1 (yeast)
Pfs2 DNA replication complex GINS protein PSF2
RNASEH2A Ribonuclease H2, large subunit
Transcription/Transcriptional Regulation
FLJ20315 Hypothetical protein FLJ20315
TBPL1 TBP-like 1
LOC89958 Hypothetical protein LOC89958
HMGN1 High-mobility group nucleosome binding domain 1
ZNF22 Zinc finger protein 22 (KOX 15)
PTTG1 Pituitary tumour-transforming 1
NFE2L3 Nuclear factor (erythroid-derived 2)-like 3
SOX9 SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal)
Transport
SLC12A2 Solute carrier family 12 (sodium/potassium/chloride transporters) member 2
CLCA1 Chloride channel, calcium activated, family member 1
LCN2 Lipocalin 2 (oncogene 24p3)
Metabolism
SORD Sorbitol dehydrogenase
TPRT Trans-prenyltransferase
QTRT1 Queuine tRNA-ribosyltransferase 1 (tRNA-guanine transglycosylase)
PAICS Phosphoribosylaminoimidazole carboxylase, Phosphoribosylaminoimidazole succinocarboxamide synthetase
DPH2L2 DPH2-like 2 (S. cerevisiae), tv-1
ALOX5 Arachidonate 5-lipoxygenase
IARS Isoleucine-tRNA synthetase, tv-short
BRIX BRIX
TK1 Thymidine kinase 1, soluble
Oncogenesis
EPHB2 EphB2 (EPHB2), tv-1
BCL11A B-cell CLL/lymphoma 11A (zinc finger protein) tv-1
MAP17 Membrane-associated protein 17
GDF15 Growth differentiation factor 15
Signalling
RACGAP1 Rac GTPase activating protein 1
mRNA Processing
LSM5 LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae)
THOC3 THO complex 3
Cell Adhesion
C20orf42 Chromosome 20 open reading frame 42H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 84
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T Ta ab bl le e   3 3. .   Genes commonly up-regulated 2-fold or more in colorectal FAP polyps compared to normal colon
S Sy ym mb bo ol l G Ge en ne e   N Na am me e
Translation
UK114 Translational inhibitor protein p14.5
Other
ZCWCC2 Zinc finger, CW-type with coiled-coil domain 2
KIAA1324 Maba1
FLJ10514 Hypothetical protein FLJ10514
ENC1 Ectodermal-neural cortex (with BTB-like domain)
PTTG2 Pituitary tumour-transforming 2
C21orf59 Chromosome 21 open reading frame 59
WDR12 WD repeat domain 12
LXN Latexin protein
Other 
KIAA1892 KIAA1892
KIAA1797 KIAA1797
GLCE Glucuronyl C5-epimerase
KIAA0101 KIAA0101 gene product
RRP46 Exosome component Rrp46
S100P S100 calcium binding protein P
PRDX4 Peroxiredoxin 4
FLJ20366 Hypothetical protein FLJ20366
F12 Coagulation factor XII (Hageman factor)
IGFBP2 Insulin-like growth factor binding protein 2 (36kD)
GW112 Differentially expressed in hematopoietic lineages
C10orf3 Chromosome 10 open reading frame 3
ATOH8 Atonal homolog 8 (Drosophila) 
MFN1 Mitofusin 1, nuclear gene encoding mitochondrial protein, tv-2
QPCT Glutaminyl-peptide cyclotransferase (glutaminyl cyclase)
UBE2S Ubiquitin-conjugating enzyme E2S
F Fi ig g. .   1 1. .   Cluster analysis of FAP polyps and mixed normal colon. The columns represent the gene expression profiles
of each sample. Green – low expression level, yellow – medium expression level, red – high expression level. The
relationships between each sample are shown by the upper dendrogram. The colouring in the upper dendrogram
represents the sample type: green (left) – normal colon; blue – colorectal FAP polyps; yellow – stomach FAP . 1 – Normal
Colon Duplicate; 2 – Normal Colon Duplicate; 3 – Colorectal FAP Polyp A Duplicate; 4 – Colorectal FAP Polyp A
Duplicate; 5 – Colorectal FAP Polyp D Duplicate; 6 – Colorectal FAP Polyp D Duplicate; 7 – Colorectal FAP Polyp B
Duplicate; 8 – Colorectal FAP Polyp B Duplicate; 9 – Colorectal FAP Polyp C Duplicate; 10 – Colorectal FAP Polyp C
Duplicate; 11 – Stomach FAP Polyp D Duplicate; 12 – Stomach FAP Polyp D Duplicate
F Fi ig g. .   2 2. .   Cluster analysis of FAP polyps, normal colon, desmoid tumours and normal fibroblasts. The columns represent
the gene expression profiles of each sample. Green – low expression level, yellow – medium expression level, red –
high expression level. The relationships between each sample are shown by the upper dendrogram. The colouring in
the upper dendrogram represents the sample type: green (left) – normal colon; blue – colorectal FAP polyps; orange
– stomach FAP polyp; green (right) – desmoid tumours; purple – fibroblast cell line. 1 – Normal Colon Duplicate; 
2 – Normal Colon Duplicate; 3 – Colorectal FAP Polyp A Duplicate; 4 – Colorectal FAP Polyp A Duplicate; 5 – Colorectal
FAP Polyp D Duplicate; 6 – Colorectal FAP Polyp D Duplicate; 7 – Colorectal FAP Polyp B Duplicate; 8 – Colorectal
FAP Polyp B Duplicate; 9 – Colorectal FAP Polyp C Duplicate; 10 – Colorectal FAP Polyp C Duplicate; 11 – Stomach
FAP Polyp D Duplicate; 12 – Stomach FAP Polyp D Duplicate; 13 – Desmoid Tumour A Duplicate; 14 – Desmoid
Tumour A Duplicate; 15 – Desmoid Tumour C Duplicate; 16 – Desmoid Tumour C Duplicate; 17 – Fibroblast Cell
Line Duplicate; 18 – Fibroblast Cell Line Duplicate 
1   2   3   4   5   6   7   8   9 10 11 12
1     3 5 7     9 11  13 15 17
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T Ta ab bl le e   4 4. .   Genes commonly down-regulated 2-fold or more in colorectal FAP polyps compared to normal colon
S Sy ym mb bo ol l G Ge en ne e   N Na am me e
Cell Cycle Control
FOSB FBJ murine osteosarcoma viral oncogene homolog B
PPP3CB Protein phosphatase 3, catalytic subunit, beta isoform (calcineurn A beta)
Cell Cycle
MXI1 MAX interacting protein 1, tv-2
CABLES1 Cdk5 and Abl enzyme substrate 1
PMP22 Peripheral myelin protein 22, tv-3
DTR Diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor)
Transcription/Transcriptional Regulation
HLX1 H2.0-like homeo box 1 (Drosophila)
NKX2-3 NK2 transcription factor related, locus 3 (Drosophila)
SOX18 SRY (sex determining region Y)-box 18
FNBP1 Formin-binding protein 1
COL4A1 Collagen, type IV, alpha 1
SIRT6 Sirtuin (silent mating type information regulation 2 homolog) 6 (S. cerevisiae)
SIRT7 Sirtuin (silent mating type information regulation 2 homolog) 7 (S. cerevisiae)
AIM1L Absent in melanoma 1-like
C19orf21 Chromosome 19 open reading frame 21
Transport
FBXO32 F-box only protein 32, tv-2
KCNMA1 Potassium large conductance calcium-activated channel, subfamily M, alpha member 1
MYADM Myeloid-associated differentiation marker
AQP8 Aquaporin 8
SLC17A4 Solute carrier family 17 (sodium phosphate), member 4
SLCO2A1 Solute carrier organic anion transporter family, member 2A1
SGK Serum/glucocorticoid regulated kinase
P2RX4 Purinergic receptor P2X, ligand-gated ion channel, 4, tv-2
SLC20A1 Solute carrier family 20 (phosphate transporter), member 1
VAMP5 Vesicle-associated membrane protein 5 (myobrevin)
Metabolism
MGC4171 Hypothetical protein MGC4171
LIPH Lipase, member H
KIAA0992 Palladin
KIAA0828 KIAA0828 protein
SULT1A2 Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2, tv-1
UPP1 Uridine phosphorylase 1, tv-1
BTNL3 Butyrophilin-like 3, tv-2
KIAA0934 KIAA0934 protein
AK1 Adenylate kinase 1
DPYSL3 Dihydropyrimidinase-like 3
PLCD1 Phospholipase C, delta 1
CA4 Carbonic anhydrase IV
SVIL Supervillin, tv-1
PC Pyruvate carboxylase, nuclear gene encoding mitochondrial protein, tv-2
TMPRSS2 Transmembrane protease, serine 2
PRSS3 Protease, serine, 3 (mesotrypsin)
PCK1 Phosphoenolpyruvate carboxykinase 1 (soluble)
ST6GALNAC6 CMP-NeuAC: (beta)-N-acetylgalactosaminide (alpha)2,6-sialyltransferase member IV
RARRES2 Retinoic acid receptor responder (tazarotene induced) 2
Tumour Suppression
PPAP2A Phosphatidic acid phosphatase type 2A, tv-1Nikola A. Bowden, Amanda Croft, Rodney J. Scott
T Ta ab bl le e   4 4. .   Genes commonly down-regulated 2-fold or more in colorectal FAP polyps compared to normal colon
S Sy ym mb bo ol l G Ge en ne e   N Na am me e
Signalling
RGL1 Ral guanine nucleotide dissociation stimulator-like 1
EFNA1 Ephrin-A1, tv-1
SDCBP2 Syndecan binding protein (syntenin) 2, tv-2
GUCA2A Guanylate cyclase activator 2A (guanylin)
BSG Basigin (OK blood group), tv-4
TRIF TIR domain containing adaptor inducing interferon-beta
ILK Integrin-linked kinase
TJP3 Tight junction protein 3 (zona occludens 3)
PRKCD Protein kinase C, delta
ITPKA Inositol 1,4,5-trisposphate 3-kinase A
IL2RG Interleukin 2 receptor, gamma (severe combined immunodeficiency)
LNK Lymphocyte adaptor protein
Cell Adhesion
PC-LKC Protocadherin LKC
DCN Decorin, tv-E
FLNA Filamin A, alpha (actin binding protein 280)
MSN Moesin
SORBS1 Sorbin and SH3 domain containing 1
TAGLN Transgelin
CDC42 Cell division cycle 42 (GTP binding protein, 25kDa), tv-2
COL4A2 Collagen, type IV, alpha 2
DBN1 Drebin 1, tv-1
GSN Gelsolin (amyloidosis, Finnish type), tv-2
ACTG2 Actin, gamma 2, smooth muscle, enteric
ACTA2 Actin, alpha 2, smooth muscle, aorta
CGN Cingulin
Apoptosis
RIPK3 Receptor-interacting serine-threonine kinase 3
FOSL2 FOS-like antigen 2
DAPK3 Death-associated protein kinase 3
LGALS1 Lectin, galactoside-binding, soluble, 1 (galactin 1)
GADD45B Growth arrest and DNA-damage-inducible, beta
Structural
CLDN5 Claudin 5 (transmembrane protein deleted in velocardiofacial syndrome)
KRT19 Keratin 19
TPM2 Tropomyosin 2 (beta)
Other
DUSP5 Dual specificity phosphatase 5
CLIPR-59 CLIP-170-related protein
PTPRR Protein tyrosine phosphatase, receptor type, R, tv-2
SMTN Smoothelin, tv-2
CEACAM1 Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
EPS8L2 EPS8-like 2
RICH1 RhoGAP interacting with CIP4 homologs 1
PDZK2 PDZ domain containing 2
CHKL Choline kinase-like, tv-1
DIP13B DIP13 beta
NS5ATP13TP2 NS5ATP13TP2 protein
M-RIP Myosin phosphatase-Rho interacting protein
MTMR9 Myotubularin related protein 9
LRRC1 Leucine rich repeat containing 1
CTGF Connective tissue growth factor
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that include E-cadhein, α-, β- and γ-catenin, COX-1,
COX-2, and c-myc [20-25]. In addition, one study used
semi-quantitative RT-PCR to study GKLF [26]. The only
report examining global gene expression in human FAP
adenoma tissue identified 84 differentially expressed genes
in adenomas compared to normal colon tissue [27]. 
In this study, the gene expression profiles obtained
from the FAP adenomas indicate that colorectal
adenomas are similar but distinctly different to the
stomach adenomas. There were a large number of
commonly expressed genes identified across the
colorectal FAP adenomas, but when the differentially
expressed genes from the stomach adenoma were
included in the analysis the number of commonly
expressed genes decreased dramatically. The genes
that were differentially expressed in the four colonic
adenomas and one stomach adenoma were
investigated more closely in an attempt to identify
common genetic features in FAP . From this analysis
genes involved in the cell cycle, transcription and
metabolism were the most frequently up-regulated. The
most frequently down-regulated genes included those
involved in metabolism, cell adhesion, signal
transduction, transcription and transport. Since
adenomas develop due to a breakdown in the fidelity
of the Wnt signalling pathway it was not surprising to
DSCR1L1 Down syndrome critical region gene 1-like 1
TU12B1-TY TU12B1-TY protein
MYH11 Myosin, heavy polypeptide 11, smooth muscle, tv-SM1
FLJ23471 MICAL-like 2, tv-2
DKFZP434B044 Hypothetical protein DKFZp434B044
MUCDHL Mucin and cadherin-like, tv-2
MMP28 Matrix metalloproteinase 28, tv-1
TRIM15 Tripartite motif-containing 15, tv-1
COL6A2 Collagen, type VI, alpha 2, tv-2C2
SELM Selenoprotein SelM
ZAK Sterile alpha motif and leucine zipper containing kinase AZK
SMTN Smoothelin, tv-3
TNXB Tenascin XB, tv-XB-S
EPS8L1 EPS8-like 1, tv-3
FLJ10350 Hypothetical protein FLJ10350
DKFZP762C186 Tangerin
TBC1D1 TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1
KIAA1145 KIAA1145 protein
PKIG Protein kinase (cAMP-dependent, catalytic) inhibitor gamma, tv-2
PKIB Protein kinase (cAMP-dependent, catalytic) inhibitor beta, tv-3
IGSF9 Immunoglobulin superfamily, member 9
LOC90313 Hypothetical protein BC004507
FLJ22582 Hypothetical protein FLJ22582
KIAA0063 KIAA0063 gene product
FSTL1 Follistatin-like 1
PRNP Prion protein (Creutzfeld-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia), tv-2
ANKRD25 Ankyrin repeat domain 25
STOM Stomatin, tv-2
FLJ46603 FLJ46603 protein
RAIN Ras-interacting protein
DHRS9 Dehydrogenase/reductase (SDR family) member 9, tv-1
LIMS2 LIM and senescent cell antigen-like domains 2
ARHGEF18 Rho/rac guanine nucleotide exchange factor (GEF) 18
KIAA0285 KIAA0285 gene product
PDLIM7 PDZ and LIM domain 7 (enigma), tv-1
CXX1 CAAX box 1
MGP Matrix GIa protein
PTPRH Protein tyrosine phosphatase, receptor type, H
SPARC Secreted protein, acidic, cysteine-rich (osteonectin)
FLJ90022 Hypothetical protein FLJ90022
SERPING1 Serine (or cysteine) proteinase inhibitor, clade G (C1 inhibitor), member 1, (angioedema, hereditary)
CSRP1 Cysteine and glycine-rich protein 1
KIAA0513 KIAA0513 gene product
OAS1 2’,5’-oligoadenylate synthetase 1, 40/46kDaH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 88
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T Ta ab bl le e   5 5. .   Genes commonly up-regulated 2-fold or more in desmoid tumours compared to normal fibroblast cells
S Sy ym mb bo ol l G Ge en ne e   N Na am me e
Cell Cycle Control
PTN Pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1)
GAS7 Growth arrest-specific 7, tv-b
CDKN1C Cyclin-dependent kinase inhibitor 1C (p57, Kip2)
TGFB3 Transforming growth factor, beta 3 
Cell Cycle
NEK3 NIMA (never in mitosis gene a)-related kinase 3, tv-2
Transcription/Transcriptional Regulation
BHLHB2 Basic helix-loop-helix domain containing, class B, 2
COL4A1 Collagen, type IV, alpha 1
COL4A2 Collagen, type IV, alpha 2
DNAJB2 DnaJ (Hsp40) homolog, subfamily B, member 2
ELF2 E74-like factor 2 (ets domain transcription factor), tv-1
EVI1 Ecotropic viral integration site 1
FKBP1A FK506 binding protein 1A, 12kDa, tv-12A
FLJ10404 Hypothetical protein FLJ10404
HDAC8 Histone deacetylase 8
JUN v-jun sarcoma virus 17 oncogene homolog (avian)
KIF2C Kinesin family member C2
NUCKS Nuclear ubiquitous casein kinase and cyclin-dependent kinase substrate
PBX2 Pre-B-cell leukemia transcription factor 2
PPIE Peptidylprolyl isomerase E (cyclophilin E), tv-2
PRR3 Proline-rich polypeptide 3
TEAD2 TEA domain family member 2
TLE2 Transducin-like enhancer of split 2 (E(sp1)) homolog, Drosophila
TLE4 Transducin-like enhancer of split 4 (E(sp1)) homolog, Drosophila
ZNF22 Zinc finger protein 22 (KOX15)
ZNF254 Zinc finger protein 254
TDRD3 Tudor domain containing 3
ZNF300 Zinc finger protein 300
MEF2C MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)
NAB1 NGFI-A binding protein 1 (EGR1 binding protein 1)
Hes4 bHLH factor Hes4
C19orf13 Chromosome 19 open reading frame 13
ARNT Aryl hydrocarbon receptor nuclear translocator, tv-2
ZNF266 Zinc finger protein 266
ZNF26 Zinc finger protein 26 (KOX 20)
MGC51082 Hypothetical protein MGC51082
TGIF2 TGFB-induced factor 2 (TALE family homeobox)
MYST3 MYST histone acetyltransferase (monocytic leukemia) 3
M96 Likely ortholog of mouse metal response element binding transcription factor 2
BAZ2B Bromodomain adjacent to zinc finger domain, 2B
Transport
NXT1 NTF2-like export factor 1
ABCA1 ATP-binding cassette, sub-family A, member 1
SLC25A29 Solute carrier family 25, member 29
SLC16A9 Solute carrier family 16 (monocarboxylic acid transporters), member 9
PSCD1 Pleckstrin homology, Sec7 and coiled-coil domains 1(cytohesin 1), tv-2
AQP1 Aquaporin 1(Channel-forming integral protein, 28kDa) tv-1
SCNN1D Sodium channel, nonvoltage-gated, delta
SLC22A17 Solute carrier family 22 (organic cation transporter), member 17, tv-2
Metabolism
SULT1A1 Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1, tv-1
CH25H Cholesterol 25-hydroxylaseH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 89
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T Ta ab bl le e   5 5. .   Genes commonly up-regulated 2-fold or more in desmoid tumours compared to normal fibroblast cells
S Sy ym mb bo ol l G Ge en ne e   N Na am me e
QTRTD1 Queuine tRNA-ribosyltransferase domain containing 1
FLJ23749 Hypothetical protein FLJ23749
FLJ10706 Hypothetical protein FLJ10706
USP52 Ubiquitin specific protease 52
RARRES2 Retinoic acid receptor responder (tazarotene induced) 2
ADAM19 A distintegrin and metalloproteinase domain 19 (meltrin beta), tv-2
AUTS2 Autism susceptibility candidate 2 
GALNT3 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3)
KIAA0140 KIAA0140
ODC-p Ornithine decarboxylase-like
PCSK5 Proprotein convertase subtilisin/kexin type 5
Oncogenesis
AKAP13 A kinase (PRKA) anchor protein 13, tv-3
MGP Matrix Gla protein
EWSR1 Ewing sarcoma breakpoint region 1, tv-EWS-b
SFRP4 Secreted frizzled-related protein 4
SRPUL Sushi-repeat protein
Signalling
GABBR1 Gamma-aminobutyric acid (GABA) B receptor, 1, tv-2
CAPS Calcyphosine, tv-2
NET1 Neuroepithelial cell transforming gene 1
PRKCH Protein kinase C, eta
PPP2R2B Protein phosphatase 2 (formerly 2A), regulatory subunit B (PR52), beta isoform, tv-4
RGS16 Regulator of G-protein signalling 16
PTHR1 Parathyroid hormone receptor 1
TMPEI Transmembrane, prostate androgen induced RNA, tv-4
ARHU Ras homolog gene family, member U
CHN1 Chimerin (chimaerin) 1
EFNB3 Ephrin-B3
GFRA2 GDNF family receptor alpha 2
GNB4 Guanine nucleotide binding protein (G protein), beta polypeptide 4
IL11RA Interleukin 11 receptor, alpha, tv-1
ITPKB Inositol 1,4,5-trisphosphate 3-kinase B
KIF13B Kinesin family member 13B
MAP4K1 Mitogen-activated protein kinase kinase kinase kinase 1
MLP MARCKS-like protein
PDGFRL Platelet-derived growth factor receptor-like
PRKCABP Protein kinase C, alpha binding protein
RASD1 RAS, dexamethasone-induced 1
TNFAIP6 Tumour necrosis factor, alpha-induced protein 6
Cell Adhesion
COL7A1 Collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive)
ISLR Immunoglobulin superfamily containing leucine-rich repeat, tv-1
Apoptosis
PPP1R13B Protein phosphatase 1, regulatory (inhibitor) subunit 13B
AXUD1 AXIN1 up-regulated 1
CASP10 Caspase 10, apoptosis-related cysteine protease, tv-B
MX1 Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse)
PCBP4 Poly(rC) binding protein 4, tv-4
TNFRSF19 Tumour necrosis factor receptor superfamily, member 19, tv-2
TNFRSF25 Tumour necrosis factor receptor superfamily, member 25, tv-7
Tumourigenesis
BARD1 BRCA1 associated RING domain 1
LOH11CR2A Loss of heterozygosity, 11, chromosomal region 2, gene A H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 90
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T Ta ab bl le e   5 5. .   Genes commonly up-regulated 2-fold or more in desmoid tumours compared to normal fibroblast cells
S Sy ym mb bo ol l G Ge en ne e   N Na am me e
Immune Response
HLA-DPA1 Major histocompatibility complex, class II, DP alpha 1
C1R Complement component 1, r subcomponent
CXCL14 Chemokine (C-X-C motif) ligand 14
IFI27 Interferon, alpha-inducible protein 27, tv-a
MX2 Myxovirus (influenza virus) resistance 2 (mouse)
RNA Processing
DHX8 DEAH (Asp-Glu-Ala-His) box polypeptide 8
HNRPA1 Heterogeneous nuclear ribonucleoprotein A1, tv-1
SFRS11 Splicing factor, arginine/serine-rich 11
Structural
ACTL6 Actin-like 6
FBLN1 Fibulin 1 (FBLN1), tv-C
FBLN1 Fibulin 1 (FBLN1), tv-D
SMTN Smoothelin, tv-2
Other
MT1H Metallothionein 1H
C12orf14 Chromosome 12 open reading frame 14
PELI1 Pellino homolog 1 (Drosophila)
IFI44 Interferon-induced protein 44
C10orf6 Chromosome 10 open reading frame 6
C2orf11 Chromosome 2 open reading frame 11
FLJ31951 Hypothetical protein FLJ31951
ISYNA1 Myo-inositol 1-phosphate synthase A1
FLJ31614 Hypothetical protein FLJ31614
AD031 AD031 protein 
CASC3 Cancer susceptibility candidate 3
GBA2 Glucosidase, beta (bile acid) 2
CGI-85 CGI-85 protein, tv-2
C14orf80 Chromosome 14 open reading frame 80
ACAS2L Acetyl-Coenzyme A synthetase 2 (AMP forming)-like, nuclear gene encoding mitochondrial protein
DTX3 Deltex 3 homolog (Drosophila)
FLJ23059 Hypothetical protein FLJ23059
PIK3R1 Phosphoinositide-3-kinase, regulatory subunit, polypeptide 1 (p85 alpha), tv-2
KIAA1223 KIAA1223
STARD9 START domain containing 9
LOC375786 Hypothetical gene supported by AL713796
SR140 U2-associated SR140 protein
MIDN Midnolin
SEC31L2 SEC31-like 2 (S. cerevisiae), tv-1
FLJ12178 Hypothetical protein FLJ12178
LOC157567 Hypothetical protein LOC157567
FLJ25005 FLJ25005 protein 
WARP von Willebrand factor A domain-related protein, tv-1
KIAA1036 KIAA1036
LOC374969 Hypothetical protein LOC374969
LOC155435 Hypothetical protein LOC155435
MGC9913 Hypothetical protein MGC9913
CASKIN2 CASK interacting protein 2
CFDP1 Craniofacial development protein 1
SPAG5 Sperm associated antigen 5
MMP23B Matrix metalloproteinase 23B
AKAP8L A kinase (PRKA) anchor protein 8-like
FLJ11029 Hypothetical protein FLJ11029
DDIT4 DNA-damage-inducible tv-4
APCDD1 Adenomatous Polyposis Coli down-regulated 1
CDW92 CDW92 antigenH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 91
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T Ta ab bl le e   6 6. .   Genes commonly down-regulated 2-fold or more in desmoid tumours compared to normal fibroblast cells
S Sy ym mb bo ol l G Ge en ne e   N Na am me e
Cell Cycle
GRN Granulin
QSCN6 Quiescin Q6
STAT1 Signal transducer and activator of transcription 1,91kDa, tv-α
STAT1 Signal transducer and activator of transcription 1,91kDa, tv-β
TIMP1 Tissue inhibitor of metalloproteinase 1 (erythroid potentiating activity, collagenase inhibitor)
Transcription/Transcriptional Regulation
HIST1H2BK Histone 1, H2bk
LOXL1 Lysyl oxidase-like 1
MSC Musculin (activated B-cell factor-1)
PRRX1 Paired related homeobox 1, tv-pmx-1b
ZDHHC14 Zinc finger, DHHC domain containing 14
Transport
GLRB Glycine receptor, beta
PCOLCE2 Procollagen C-endopeptidase enhancer 2
SCAMP3 Secretory carrier membrane protein 3, tv-1
SLC31A2 Solute carrier family 31 (copper transporters), member 2
Metabolism
AK1 Adenylate kinase 1
AKR1C3 Aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)
C1RL Complement component 1, r subcomponent-like
COMT Catechol-O-methyltransferase, tv-MB-COMT
CTSL Cathepsin L, tv-2
GCLM Glutamate-cysteine ligase, modifier subunit
GNPDA2 Glucosamine-6-phosphate deaminase 2
IDH1 Isocitrate dehydrogenase 1 (NADP+), soluble
NQO1 NAD(P)H dehydrogenase, quinone 1
PTGIS Prostaglandin I2 (prostacyclin) synthase
SMPDL3A Sphingomyelin phosphodiesterase, acid-like 3A
SPPL2A Putative intramembrane cleaving protease
STS Steroid sulfatase (microsomal), arylsulfatase C, isozyme S
UBE2G1 Ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, C. elegans), tv-1
UCHL1 Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
Tumour Suppression
MADH3 MAD, mothers against decapentaplegic homolog 3 (Drosophila)
Signalling
DEPDC6 DEP domain containing 6
DIRAS1 DIRAS family, GTP-binding RAS-like 1
PDGFRA Platelet-derived growth factor receptor, alpha polypeptide
PENK Proenkephalin
SARA2 SAR1a gene homolog 2 (S. cerevisiae)
SNTB1 Syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1)
DKFZp564I1922 Adlican
mRNA Processing
CSTF1 Cleavage stimulation factor, 3’ pre-RNA, subunit 1, 50kDa
Cell Adhesion
CNTNAP1 Contactin-associated protein 1
THBS2 Thrombospondin 2
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T Ta ab bl le e   6 6. .   Genes commonly down-regulated 2-fold or more in desmoid tumours compared to normal fibroblast cells
S Sy ym mb bo ol l G Ge en ne e   N Na am me e
Apoptosis
C20orf97 Chromosome 20 open reading frame 97
DAPK1 Death-associated protein kinase 1 
MAPK1 Mitogen-activated protein kinase 1, tv-1
Structural
KRT18 Keratin 18, tv-1
TUBG1 Tubulin, gamma 1
Immune Response
ANKRD15 Ankyrin repeat domain 15, tv-1
DPP4 Dipeptidylpeptidase 4 (CD26, adenosine deaminase complexing protein 2)
MR1 Major histocompatibility complex, class I-related 
Other
ANGPTL2 Angiopoietin-like 2 
ANTXR2 Anthrax toxin receptor 2
BCKDHB Branched chain keto acid dehydrogenase E1, beta polypeptide (maple syrup urine disease), nuclear gene 
encoding mitochondrial protein, tv-2
BZRP Benzodiazapine receptor (peripheral), tv-PBR-S
C11orf17 Chromosome 11 open reading frame 17, tv-2
C6orf32 Chromosome 6 open reading frame 32
C9orf88 Chromosome 9 open reading frame 88
CDC42EP2 CDC42 effector protein (Rho GTPase binding) 2
CRLF1 Cytokine receptor-like factor 1
DIRC2 Disrupted in renal carcinoma 2
EDEM1 ER degradation enhancer, mannosidase alpha-like 1
FLJ20073 FLJ20073 protein 
FLJ20272 Hypothetical protein FLJ20272
FLJ22582 Hypothetical protein FLJ22582
HOM-TES-103 HOM-TES-103 tumour antigen-like, tv-3
HSPC157 HSPC157 protein
KIAA0196 KIAA0196 gene product
LOC196463 Hypothetical protein LOC196463
LOC221091 Similar to hypothetical protein 
LOC286343 Hypothetical protein LOC286343
LOC387908 Similar to Ferritin heavy chain (Ferritin H subunit)
LOC57168 Similar to aspartate beta hydroxylase (ASPH)
LRRFIP2 Leucine rich repeat (in FLII) interacting protein 2
LYPLA1 Lysophospholipase I
MGC12992 Hypothetical protein MGC12992
MGST1 Microsomal glutathione S-transferase 1, tv-1a
MOCOS Molybdenum cofactor sulfurase
NNT Nicotinamide nucleotide transhydrogenase
PKM2 Pyruvate kinase, muscle, tv-1
PPAP2B Phosphatidic acid phosphatase type 2B, tv-2
PSFL Anterior pharynx defective 1B-like 
PTX3 Pentaxin-related gene, rapidly induced by IL-1 beta
S100A4 S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog), tv-2
SLIT3 Slit homolog 3 (Drosophila)
SMP1 Small membrane protein 1
TRIM4 Tripartite motif-containing 4, tv-β
UNQ564 UNQ564
ZC3HAV1 Zinc finger CCCH type, antiviral 1, tv-2H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 93
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observe the over-expression of genes involved in cell
cycle progression. 
A Al lt te er re ed d  E Ex xp pr re es ss si io on n  o of f  W Wn nt t/ /β β- -c ca at te en ni in n  T Ta ar rg ge et t  G Ge en ne es s  
i in n  C Co ol lo or re ec ct ta al l  F FA AP P  A Ad de en no om ma as s
It has been long established that deregulation of 
the Wnt signalling pathway due to APC mutations 
plays a major role in the progression of FAP [5]. The
Wnt/β-catenin signalling pathway is involved in the
control of expression of Sox9, PTTG1 and EphB2, all
of which were found to be up-regulated by more than
2-fold in all the colorectal FAP adenomas compared
to the normal colon.
PTTG1 is regulated by a TCF binding sequence in
its promoter region [28]. The normal function of PTTG1
is to regulate chromosome segregation during cell
division [29]. Over-expression of PTTG1 has been
reported frequently in various types of cancer, including
colorectal, and has been associated with angiogenesis
[30-32]. The role of PTTG1 in angiogenesis is thought
to be a result of its part in mediating the secretion of
the basic fibroblast growth factor into the extracellular
matrix, which promotes proliferation and migration of
colorectal cancer cells [30, 31]. 
The Sox9 gene encodes a transcription factor that is
required for chondrogenesis and male gonad
development [32], which is under the control of the Wnt
signalling pathway [33]. The expression of the Sox9 gene
in the intestine is dependent on the activity of the 
β-catenin/TCF-4 complex, although it is unknown
whether this complex interacts directly with the Sox9
promoter or through another of its targets [33]. 
The EphB2 gene encodes the Eph receptor B, which
has been shown to be a target of the Wnt signalling
pathway [34]. There is evidence to suggest that normal
patterning in the epithelium of the intestinal crypts is
coordinated by EphB2 and its ligand, ephrin B [34].
Over-expression of EphB2 is often found in colorectal
cancers, but there is confusion about its role in
tumourigenesis. Many studies on other tumours have
reported EphB2 over-expression as a marker of poor
prognosis, but recent studies in colorectal cancer have
suggested otherwise [35, 36]. 
A Al lt te er re ed d  E Ex xp pr re es ss si io on n  o of f  C Ce el ll l  C Cy yc cl le e- -R Re el la at te ed d  G Ge en ne es s  
i in n  C Co ol lo or re ec ct ta al l  F FA AP P  A Ad de en no om ma as s
A number of genes found to be commonly up-
regulated in the adenomas used in this study have
previously been reported as being over-expressed in
various types of cancers. These genes include the cell
cycle-related genes Chromosome condensation protein
G (HCAP-G), Protein regulator of cytokinesis 1 (PRC1),
SMC4 structural maintenance of chromosome 4-like 
1 (SMC4L1) and Cyclin B2 (CCNB2) [37-39]. Although
these genes are associated with tumour development
none have been thoroughly characterized in FAP 
to date.
A Al lt te er re ed d  G Ge en ne e  E Ex xp pr re es ss si io on n  i in n  D De es sm mo oi id d  T Tu um mo ou ur rs s
A limited number of gene expression studies have
been performed on desmoid tumours, primarily due to
the difficulties in obtaining tissue. Two reports have studied
gene expression in desmoid disease using 6.8K, 19K and
33K Affymetrix microarrays [40, 41]. Skubitz and Skubitz
(2004) [40] reported that ADAM12, WISP-1, 
Sox-11 and fibroblast activation protein-α are uniquely
expressed in desmoids. Denys et al. (2004) identified 
69 differentially expressed genes in desmoid tumour tissue
compared to normal fibroblasts, before focusing on the
down-regulation of IGFBP-6 [41]. 
A number of genes that were identified as being
differentially expressed in desmoid tumours in this study
have been reported previously. The over-expressed
genes include transforming growth factor β3 (TGFβ3),
a distintegrin and metalloproteinase domain 19
(ADAM19), chimerin 1 (CHN1), and ephrin-B3
(EFNB3) [40, 41]. The under-expressed genes include
quiescin Q6 (QSCN6), prostaglandin I2 synthase
(PTGIS), proenkephalin (PENK), keratin 18 (KRT18),
cytokine receptor-like factor 1 (CRLF1), pentaxin-related
gene (PTX3) and endoglin (ENG) [41]. 
E Ep ph hr ri in n- -B B3 3,,  a a  W Wn nt t  T Ta ar rg ge et t  O Ov ve er re ex xp pr re es ss se ed d  i in n  D De es sm mo oi id d  T Tu um mo ou ur rs s
The known Wnt/β-catenin target gene ephrin-B3
[42] has been found in this study to be up-regulated
more than 2-fold in desmoid tumours compared to
normal fibroblasts. The ephrins are ligands for the EPH
receptor family, whose normal function is to organize
cell patterning in the intestinal crypts [34]. In addition,
more recent observations suggest that ephrins are
tumour suppressors, although the mechanism by which
this is affected remains to be clarified [3, 43, 44].
Further investigation into the precise role of ephrin-B3
is required before any conclusions can be made
regarding its role in desmoid disease.
W Wo ou un nd d  H He ea al li in ng g- -A As ss so oc ci ia at te ed d  G Ge en ne es s  D Di if ff fe er re en nt ti ia al ll ly y  E Ex xp pr re es ss se ed d  
i in n  D De es sm mo oi id d  T Tu um mo ou ur rs s
Two genes, transforming growth factor β-3 (TGFβ3)
and pleiotrophin (PTN), were found to be differentially
expressed in desmoid tumours. Both genes areH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 94
associated with wound healing and could potentially
explain the growth advantage of desmoid tumours [45]. 
TGFβ3 is a multifunctional protein, having roles in
cell proliferation and differentiation during embryogenesis
and wound healing [46]. Pleiotrophin has been reported
to be strongly expressed in many human cancers, and is
thought to promote malignant transformation and
angiogenesis [47]. It is also frequently found to be up-
regulated during the wound healing process [48]. 
In this study, three genes associated with negative
regulation of the wound response have been identified
as being under-expressed in desmoid tumours. The three
genes are: signal transducer and activator of
transcription 1 (STAT1), mothers against decapentaplegic
homolog 3 (MADH3 or Smad3) and mothers against
decapentaplegic homolog 6 (MADH6 or Smad6). STAT1
enhances transcription in response to interferon-γ, an
action which has been shown to inhibit the wound
healing response by preventing phosphorylation of
Smad2 and Smad3 [49]. This in turn inhibits the action
of TGFβ on the wound response [50]. The role of
Smad3 in the wound response is not entirely understood;
however, the absence of Smad3 causes an accelerated
healing response, even though its over-expression has
also been shown to promote healing [51, 52]. Smad6
is a known inhibitor of TGFβ, and has shown to be
down-regulated in keloids [53]. 
The abundance of wound response-related genes
found to be deregulated in the desmoid tumours in this
study adds to the notion that desmoid formation is an
abnormal wound response. The finding of over-
expressed genes involved in fibroblast proliferation and
migration could explain the abnormal proliferation and
local invasiveness of desmoid tumours. The down-
regulation of angiogenesis-associated genes could
account for the poor vascularisation of desmoids.
The limiting factor in this study of desmoid tumours
is the small number of desmoids available. In order to
reach more conclusions regarding the exact molecular
nature of desmoids and their growth mechanisms, 
a much larger sample size would be required. 
C Co om mp pa ar ri is so on n  o of f  F FA AP P  A Ad de en no om ma a  a an nd d  D De es sm mo oi id d  T Tu um mo ou ur r
M Mo ol le ec cu ul la ar r  P Pr ro of fi il le es s
It has long been recognized that desmoid tumours
occur with a much higher frequency in FAP patients
than in the general population. The apparent role of
aberrant Wnt signalling in both diseases could indicate
a molecular similarity between the two. Although Wnt
target genes were identified as being up-regulated in
both tumour types in this study, the specific genes were
different in the two groups. The finding of different Wnt
targets could be attributed to the use of different control
groups for the FAP adenomas and desmoid tumours.
Nevertheless, the molecular profiles obtained using
cluster analysis clearly demonstrated that FAP
adenomas and desmoid tumours display distinctly
different gene expression profiles. 
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